Stifel Financial’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
Stifel Financial's RGNX Position: Q3 2026 in Review
Stifel Financial reduced its Regenxbio (RGNX) stake by 14% in Q3 2026, selling an estimated $794K and leaving 482,509 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.
Stifel Financial first reported a position in RGNX in Q2 2021 and has held it in 22 quarters since. The position peaked at $6.72M in Q2 2026. 174 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.
- Stifel Financial held 482,509 shares of Regenxbio worth $3.63M as of Q3 2026.
- Stifel Financial sold 78,218 Regenxbio shares in Q3 2026, an estimated $794K.
- Regenxbio made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #1626 holding.
- Stifel Financial first reported a position in Regenxbio in Q2 2021 and has held it in 22 quarters since.
- Stifel Financial's Regenxbio position peaked at $6.72M in Q2 2026.
- 174 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.